Clinical Trial Update: Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating cannabidiol to prevent graft-versus-host disease in patients receiving allogeneic stem cell transplants, spanning Phase 1 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Rabin Medical Center | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: UNKNOWN